Skip to main content
Videos

Novel Hair Growth Therapies: Exosomes, Microneedling, and Emerging Regenerative Treatments

Clinical Summary

Novel Hair Growth Therapies: Exosomes, Microneedling, and Regenerative Approaches

  • Emerging therapies: Microneedling combined with topical exosome-containing serums showed the most impressive photographic improvements among emerging hair restoration approaches and may appeal to patients seeking nonpharmacologic options.

  • Targeted biology: Advances in understanding Wnt/β-catenin, VEGF, fibroblast growth factors, and inflammatory signaling are driving new therapies, including GHK-based stimulants and supplements aimed at supporting follicle health and reducing inflammation.

  • Clinical considerations: Prioritize safety data when adopting new therapies; topical treatments appear reassuring, while injectables require greater caution, and oral therapies should await FDA approval before routine clinical use.

Reviewed by Riya Gandhi, MA, Associate Editor of Immunology Group

Dr Carolyn Jacob discusses emerging therapies that are expanding hair restoration beyond traditional treatments like minoxidil and finasteride. Learn how exosome-based serums, microneedling, growth factor signaling pathways, and regenerative approaches may improve hair growth, along with practical considerations for safely incorporating newer and investigational therapies into clinical practice.

Transcript

I'm Dr Carolyn Jacob, Director of Chicago Cosmetic Surgery and Dermatology in downtown Chicago.

What emerging therapies show the most promise for improving hair growth outcomes beyond traditional treatments like minoxidil and finasteride?

Dr Jacob: Everyone is into hair growth these days. We have lots of reasons for people to be losing their hair from viruses to stressors to GLP-1 agonists. In my study and discussion about novel therapies for hair growth, the most impressive results, at least photography-wise, were with using microneedling with topical serums that contained exosomes. So I think this is a really hot topic. I think that that's very easy for these to be applied. Most people have a microneedling device in their office, and I think that plus the supplements is always a home run for patients, especially for those who want to avoid side effects from medications. 

How are advances in our understanding of hair follicle biology and signaling pathways translating into new, targeted treatment options?

Dr Jacob: We've learned so much about the hair follicle growth pathway and all of the different signaling molecules, such as Wnt/β-catenin, which are very, very important, but also fibroblast growth factors and VEGF, et cetera. So there's so many different ways that we can use different molecules to improve the hair growth. It's very exciting. So anywhere from the GHK stimulants to help with VEGF growth and help with follicle health to supplements which help to calm down inflammation that we know is a big stressor that leads to hair loss. So we have lots and lots of different approaches for the treatment of hair loss now which makes it a wide variety of options to give to our patients. And it's really great because we can kind of sort it out for each patient based on their own individual needs. 

What practical considerations should clinicians keep in mind when incorporating newer or investigational therapies into patient care?

Dr Jacob: Always with newer or investigational therapies, we want to ensure that they're safe first. So safety data is key before you use something on someone or have them ingest it. And I think there's a lot of good data about some of the newer treatments and trials that are out there for hair loss and for skin rejuvenation. So I think that we're really safe with the topicals. We have to be a little bit more cautious with any of the injectables and then definitely wait for FDA approval for any oral medication. 

© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of The Dermatologist or HMP Global, their employees, and affiliates.